BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...

February 13, 2026 | News

WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...

February 13, 2026 | News

GCCL And Medicover Integrated Clinical Services Sign MOU To Strengthen Multinational Trial Delivery

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an internation...

February 12, 2026 | News

Helix Partners With Mawi DNA To Broaden Access To Non Invasive Genomic Sample Collection

Helix, the leading enterprise genomics company, has partnered with Mawi DNA Technologies, a leader in DNA sample collection and storage, to expa...

February 12, 2026 | News

Made Scientific And Streamline Bio Launch Exclusive AI Driven Early Adopter Programme For GMP Ready Cell Therapy Manufacturing

Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, I...

February 12, 2026 | News

CaseBioscience Launches Cell Therapy Grade Cryopreservation And Hypothermic Storage Solutions At Advanced Therapies Week 2026

Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performa...

February 10, 2026 | News

Innovent Biologics And Eli Lilly Expand Oncology And Immunology Alliance With Global Development Model

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

February 10, 2026 | News

Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104

Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...

February 09, 2026 | News

Samsung Biologics PCF System Validated Against Global Carbon Accounting Standards

Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish ...

February 09, 2026 | News

SanegeneBio Licenses RNAi Programme To Genentech In Global Deal Valued Up To USD 1.7 Billion

SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million up...

February 04, 2026 | News

Novo Nordisk Secures US FDA Approval For Once Daily Oral GLP 1 Weight Management Pill

The US Food and Drug Administration (FDA) has approved Novo Nordisk's new once-daily pill for weight management, designed to help people reduce excess body...

January 29, 2026 | News

Hanmi Pharmaceutical Advances Global GLP 1 Strategy With Mexico Distribution Agreement For Efpeglenatide

Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obesity and metabolic disease ...

January 29, 2026 | News

Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad

As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is ...

January 19, 2026 | News

Fresenius Kabi And TQ Therapeutics Sign Strategic Agreement To Scale T Cell Manufacturing For Cell And Gene Therapy

Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced today they have entered into a strategic-development agreement under...

January 16, 2026 | News

Stay Connected